BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12230840)

  • 1. How can you patent genes?
    Eisenberg RS
    Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patenting genes? A finger in the dike of a bricks-and-mortar patent system.
    White GB
    Am J Bioeth; 2002; 2(3):20. PubMed ID: 12230846
    [No Abstract]   [Full Text] [Related]  

  • 3. Patenting DNA: who defines and protects the public good?
    Garcia SA
    Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property and products of nature.
    Sagoff M
    Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841
    [No Abstract]   [Full Text] [Related]  

  • 5. Locating gene patents within the patent system.
    Rai AK
    Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
    [No Abstract]   [Full Text] [Related]  

  • 6. What's the use? Law and authority in patenting human genetic material.
    Kahn J
    Stanford Law Pol Rev; 2003; 14(2):417-44. PubMed ID: 15212025
    [No Abstract]   [Full Text] [Related]  

  • 7. No patents for semantic information.
    Wilson J
    Am J Bioeth; 2002; 2(3):15-6. PubMed ID: 12230843
    [No Abstract]   [Full Text] [Related]  

  • 8. Intellectual property and biotechnology: the U.S. internal experience--Part II.
    Brody B
    Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovations and intellectual property: the case of genomic patenting.
    Jackson BA
    J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two meanings of how and the gene patenting debate.
    Evans JH
    Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic patenting and the utility requirement.
    Calvert J
    New Genet Soc; 2004 Dec; 23(3):301-12. PubMed ID: 15828153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence patents are not the issue.
    Robertson JA
    Am J Bioeth; 2002; 2(3):22-3. PubMed ID: 12230848
    [No Abstract]   [Full Text] [Related]  

  • 13. Invisible genomes: the genomics revolution and patenting practice.
    Bostanci A; Calvert J
    Stud Hist Philos Biol Biomed Sci; 2008 Mar; 39(1):109-19. PubMed ID: 18331958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
    Crespi RS
    Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patenting of genetic material: are the benefits to society being realized?
    Willison DJ; MacLeod SM
    CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174
    [No Abstract]   [Full Text] [Related]  

  • 16. Waiting on science: the stake of present and future patients.
    Quigley RB
    Am J Bioeth; 2002; 2(3):17-8. PubMed ID: 12230844
    [No Abstract]   [Full Text] [Related]  

  • 17. Intellectual property. Enhanced: intellectual property landscape of the human genome.
    Jensen K; Murray F
    Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public access versus proprietary rights in genomic information: what is the proper role of intellectual property rights?
    Mueller JM
    J Health Care Law Policy; 2003; 6(2):222-40. PubMed ID: 15017961
    [No Abstract]   [Full Text] [Related]  

  • 20. Patenting genes and the public interest.
    Nelkin D
    Am J Bioeth; 2002; 2(3):13-5. PubMed ID: 12230842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.